The efficacy and efficiency of medical genetics depend on the level of knowledge among physicians, the thoroughness
of analysis conducted, and the diagnostic capabilities concerning pathologies that are relatively uncommon within the population. This allows maximum assistance to patients with congenital and hereditary diseases and improves their quality of life. In recent years, despite the undeniable
achievements of medical genetics, there has been an increase in genetically determined pathologies, a trend often linked to the intensification of the mutagenic influence of a polluted environment, the increase in the diagnosis of genetic diseases, and the development of new methods for
diagnosing hereditary pathologies. Therefore, the relevance and significance of this work are beyond doubt.
The textbook authored by Doctors of Medical Sciences and professors Kitsera N.I., Kovalchuk L.Y., and Cherniuk N.V., titled “Genetic Pathology and Its Bronchopulmonary Manifestations,” is dedicated to advancing the knowledge of bronchopulmonary pathology in hereditary diseases among physicians and medical students. This book represents the first scholarly work to comprehensively elucidate the essence of various chromosomal (such as Patau syndrome and Edwards syndrome), monogenic (such as Ehlers-Danlos syndrome and Osler-Weber-Rendu syndrome), X-linked, and multifactorial syndromes encountered in children, as well as describes pulmonary and bronchial complications associated with these conditions.

Objective: The relevance of this study is conditioned by the need for urgent search and implementation of effective methods of treatment of urinary system diseases in people of different ages, as well as addressing issues of quality treatment of connective tissue diseases in general and its dysplasia in particular. The aim of the article is to identify congenital defects as visceral markers of connective tissue dysplasia.
Methods: The methodology of this study includes a survey of a group of children with considerable problems in the development and functioning of the urinary system at the age of 2 weeks to 3 years, in order to qualitatively select and determine the most effective methods of treatment. Children who took part in this study had a set of phenotypic and clinical properties of undifferentiated connective tissue dysplasia.
Results: The considerable prevalence of undifferentiated connective tissue dysplasia in young children with congenital malformations of the urinary system, especially in children with abnormal development and functioning of kidney tissue, which substantially influences the course of the disease was determined. Also, treatment of undifferentiated connective tissue dysplasia was predicted.

Conclusions: It was concluded that the presence of a malformation of the urinary system, which is acquired by a child from birth, can be considered as a visceral manifestation of undifferentiated connective tissue dysplasia.

The growing number, prevalence, numerous complications, and deaths in patients with congenital anomalies of the kidney and urinary tract
(CAKUT) indicate the high relevance of the declared topic. Currently, clinical medicine is actively engaged in research on the cellular and molecular mechanisms that cause the appearance of these diseases.

Aim: The aim of the work is to study genetic markers of CAKUT and the tendency to a more severe course of pyelonephritis in young children.

Material and methods: Using the multiplex polymerase chain reaction method, 50 children with pyelonephritis were examined for the presence of deletion alleles of the glutathione S-transferase mu 1 (GSTM1) and glutathione S-transferase theta 1 (GSTT1) genes.

Results and discussion: As a result, 35 children were diagnosed with certain CAKUT. A statistically significant associative relationship between the development of pyelonephritis in a child and the presence of a null allele GSTM1 0/0 in its genotype and a high probability of CAKUT with quantitative and positional anomalies and impaired formation and differentiation of renal tissue in carriers of null alleles GSTT1 0/0, GSTM1 0/0 in their combination was revealed.
Conclusions: The fact that different forms of abnormalities are detected in members of the same family suggests that certain genetic mutations can potentially lead to CAKUT syndrome, but the final phenotype of the renal system depends either on the genetic background or on environmental factors.

The purpose of this study is to substantiate the choice and evaluate the efectiveness of therapeutic tactics aimed at suppressing collagen formation and improving metabolic processes in the kidney parenchyma in young children with pyelonephritis against the background of vesicoureteral refux associated with undiferentiated tissue dysfunction. 67 children from 2 weeks to 3 years old with pyelonephritis and vesicoureteral refux were examined. All children during the period of remission of the infammatory process were examined for the content of oxyproline in the urine. Urine crystallinity and urinary excretion were determined, and markers of the morphofunctional state of the cytomembranes of the renal epithelium were determined: calcifcation test—the presence of polar lipids in the urine and test for the presence of lipid peroxidation products in the urine.
Children with high urinary hydroxyproline excretion prior to protocol treatment of pyelonephritis during the remission of the infammatory process at the stage of maintenance therapy were recommended to receive metabolic preparations that can inhibit collagen formation and improve parenchyma metabolic processes during the month—vitamin E 10% and l-carnitine in age-related doses. After 6 months, a study was made on the functional state of the renal parenchyma in the dynamics of treatment. After metabolic antihypoxic and membrane-protective therapy, there was a signifcant positive dynamic of all markers of tissue hypoxia and membrane destruction in the kidney parenchyma, which confrms the inhibition of collagen formation processes and a decrease in tissue hypoxia with vitamin E and l-carnitine in age-related doses.

The high incidence of children with recurrent episodes of acute obstructive bronchitis is a widespread problem. Correct identification of children at risk of developing bronchial asthma at school age may improve treatment and prevention approaches to this pathology, but the ability to identify these children remains limited. The purpose of the study was to determine the effectiveness of recombinant interferon alpha-2β in children with recurrent episodes of acute obstructive bronchitis in the course of treatment based on the assessment of cytokine profile. The study examined 59 children of the main group with recurrent episodes of acute obstructive bronchitis and 30 children of the comparison group who suffered from acute bronchitis, aged 2–8 years, who were in the hospital. The results of laboratory studies were compared with the data of 30 healthy children. In children with recurrent episodes of acute obstructive bronchitis, the content of serum interferon-γ and interleukin-4 was significantly reduced compared to healthy children, after treatment with recombinant human interferon alpha-2β, the content of interferon-γ and interleukin-4 in children significantly increased. The content of interleukin-1β in children with recurrent episodes of acute obstructive bronchitis was significantly higher than in healthy children, after immunomodulatory therapy with recombinant interferon alpha-2β, interleukin-4 normalized to its level in healthy children. It was found that children with recurrent episodes of acute obstructive bronchitis have an imbalance of cytokines, the effectiveness of recombinant human interferon alpha-2β therapy, which normalized the levels of the studied cytokines in the serum.